C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions

Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
11/2002
11/14/2002	WO2002090979A1 Biochips and method of screening using drug induced gene and protein expression profiling
11/14/2002	WO2002090978A1 Method and apparatus for high-speed approximate sub-string searches
11/14/2002	WO2002090974A2 Method for detecting progredient chronic dementia, and associated peptides and detection reagents
11/14/2002	WO2002090970A1 Proteome analysis method
11/14/2002	WO2002090969A1 Method of identifying phosphoprotein
11/14/2002	WO2002090945A2 Method of performing an assay, apparatus therefor, and a method of manufacturing and apparatus
11/14/2002	WO2002090934A2 Evaluation of ultraviolet radiation damage to skin using new genemarkers, methods and compositions related thereto
11/14/2002	WO2002090931A2 Methods for determining the prognosis for cancer patients using tucan
11/14/2002	WO2002090930A2 Stabilizing peroxides with stannous halides
11/14/2002	WO2002090926A2 Dose response-based methods for identifying receptors having alterations in signaling
11/14/2002	WO2002090924A2 Mutation induced optimization of receptor signal to noise ratio
11/14/2002	WO2002090600A2 A method for regulating immune function in primates using the foxp3 protein
11/14/2002	WO2002090599A1 Universal microarray system
11/14/2002	WO2002090598A2 Methods for the identification of inhibitors of flavanone 3-hydroxylase expression or activity in plants
11/14/2002	WO2002090597A1 Haplotypes of the cyp2e gene
11/14/2002	WO2002090596A1 Methods for the identification of inhibitors of biotim synthase expression or activity in plants
11/14/2002	WO2002090593A1 Screening for enzyme inhibitors
11/14/2002	WO2002090589A1 Method to find disease-associated snps and genes
11/14/2002	WO2002090587A1 Retrovirus-specific oligonucleotides and a method for measuring retroviral titer using same
11/14/2002	WO2002090586A2 Analytical method and kit
11/14/2002	WO2002090585A2 Genetic polymorphism pattern of tgfb1 as marker for susceptability to renal disease
11/14/2002	WO2002090584A2 Method for labelling and fragmenting dna
11/14/2002	WO2002090583A2 Skin treatment
11/14/2002	WO2002090582A2 Nucleic acid sequences and a method for genus-, group-, species- and sub-species-specific detection of mycobacteria
11/14/2002	WO2002090581A2 A molecular tag code for monitoring a product and process using same
11/14/2002	WO2002090580A1 Identifying liver cancer by detecting aberrant expression of insulin like growth factor binding protein
11/14/2002	WO2002090579A1 Bioinformatics based system for assessing a condition of a performance animal by analysing nucleic acid expression
11/14/2002	WO2002090578A2 Methods and means of histone methylation
11/14/2002	WO2002090577A2 Positive response biosensors and other sensors
11/14/2002	WO2002090576A1 Methods and compositions for the treatment and diagnosis of body weight disorders
11/14/2002	WO2002090575A1 An assay for detecting inhibitors of the enzyme mueloperokidase
11/14/2002	WO2002090573A2 Biochip arrangement
11/14/2002	WO2002090572A2 Nucleic acid detection in pooled samples
11/14/2002	WO2002090569A2 Family-based association tests for quantitative traits using pooled dna
11/14/2002	WO2002090567A2 Sperm-specific cation channel, and uses therefor
11/14/2002	WO2002090564A1 Methods for gene expression profiling
11/14/2002	WO2002090563A1 Methods for the reduction of stutter in microsatellite amplification using sorbitol
11/14/2002	WO2002090562A2 Methods for the reduction of stutter in microsatellite amplification
11/14/2002	WO2002090561A1 Methods and composition for nucleic acid amplification
11/14/2002	WO2002090548A1 Method of purifying chromosomal dna replication initiating protein dnaa of pathogenic bacterium using affinity of dnaa protein for atp, method of evaluating antibacterial activity and method of screening compound having antibacterial activity using affinity of dnaa protein for atp
11/14/2002	WO2002090546A1 Polypeptide serving as angiogenic marker and dna thereof
11/14/2002	WO2002090543A2 Regulation of human phosphatidic acid phosphatase type 2c-like protein
11/14/2002	WO2002090541A1 Determination of a genetic predisposition for behavioural disorders
11/14/2002	WO2002090538A1 Method of synthesizing nucleic acid
11/14/2002	WO2002090532A1 Novel mutation
11/14/2002	WO2002090531A2 Peptidylarginine deiminase 6
11/14/2002	WO2002090530A2 Kinases and phosphatases
11/14/2002	WO2002090524A2 Isolated nucleic acid molecules encoding a novel human signal transducing kinase-mapkap-2; encoded proteins, cells transformed therewith and uses thereof
11/14/2002	WO2002090520A2 Toll/interleukin-1 receptor adaptor protein (tirap)
11/14/2002	WO2002090516A2 Design of artificial genes for use as controls in gene expression analysis systems
11/14/2002	WO2002090512A2 Haplotypes of the nnmt gene
11/14/2002	WO2002090505A2 Multiple sequencible and ligatible structures for genomic analysis
11/14/2002	WO2002090504A2 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
11/14/2002	WO2002090503A2 Anti-microbial peptides and compositions
11/14/2002	WO2002090499A2 ss-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
11/14/2002	WO2002090498A2 A high throughput assay for identification of gene expression modifiers
11/14/2002	WO2002090443A1 Synthesis and evaluation of new cyanine dyes as minor groove of [poly(da-dt)]2 binders
11/14/2002	WO2002090382A2 Mixture of peptides derived from e6 and/or e7 papillomavirus proteins and uses thereof
11/14/2002	WO2002090378A2 Haplotypes of the ces2 gene
11/14/2002	WO2002090374A1 Approaches to identify genetic traits
11/14/2002	WO2002090319A1 Labelling reagents, method for synthesis of said reagents and methods for detecting biological molecules
11/14/2002	WO2002090112A1 Polymer bonding by means of plasma activation
11/14/2002	WO2002089844A1 Legionella detection with fluorescent resonance energy transfer
11/14/2002	WO2002089832A2 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio.
11/14/2002	WO2002089829A2 Polymorphism in the eosinophil cationic protein (ecp) used in the treatment of e.g. cancer
11/14/2002	WO2002089747A2 Compositions and methods for the therapy and diagnosis of prostate cancer
11/14/2002	WO2002089739A2 Peptide deformylase activated prodrugs
11/14/2002	WO2002089736A2 Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment
11/14/2002	WO2002089657A2 Diagnostic markers of acute coronary syndromes and methods of use thereof
11/14/2002	WO2002089586A1 Lung epithelial cell line for propagating viruses
11/14/2002	WO2002089567A2 Sca2 knockout animal and methods of use
11/14/2002	WO2002089561A1 Tyra genes and uses thereof
11/14/2002	WO2002079393A9 Dynamic action reference tools
11/14/2002	WO2002077259A3 Biochips including ion transport detecting structures and methods of use
11/14/2002	WO2002074904A3 Rearranged squamous cell carcinoma antigen genes ii
11/14/2002	WO2002074326A3 Urocortin-iii and uses thereof
11/14/2002	WO2002067764A3 Alzheimer's disease diagnosis based on mitogen-activated protein kinase phosphorylation
11/14/2002	WO2002066028A3 Pharmaceutical compositions containing fluorinated or perfluorinated carboxylic acids
11/14/2002	WO2002062370A3 Stabilization of hypoallergenic, hyperdigestible previously reduced proteins
11/14/2002	WO2002061122A3 New method for genotype determination
11/14/2002	WO2002028906A3 Regulation of human sphingosine kinase-like protein
11/14/2002	WO2002022650A3 Haplotypes of the per1 gene
11/14/2002	WO2002018623A3 Methods and reagents for protease inhibition
11/14/2002	WO2001098785B1 Rapid flow-based immunoassay microchip
11/14/2002	WO2001088530A3 Method for selecting enzyme inhibitors
11/14/2002	WO2001075155A3 Methods for detecting of nucleic acid amplification reaction products
11/14/2002	WO2001062984A3 Detection of human papilloma viruses
11/14/2002	WO2001048244A3 Detection of single nucleotide polymorphisms
11/14/2002	WO2001042511A3 Ibd-related polymorphisms
11/14/2002	WO2001040504A9 Methods and compositions for detecting nitroaromatic compounds
11/14/2002	WO2001036659A3 Selectable cell surface marker genes
11/14/2002	WO2001033228A3 Cancer diagnosis employing cell-sorting and gene-profiles
11/14/2002	WO2001032931A9 Method and compositions for selectively inhibiting amplification of sequences in a population of nucleic acid molecules
11/14/2002	WO2001021758A9 Colorimetric test for agents that induce mitrochondrial dysfunction
11/14/2002	WO2001007030A3 Compositions an inhibitor of an accrab-like efflux pump for reducung microbial resistance to drugs
11/14/2002	US20020169309 Mutation detection method
11/14/2002	US20020169304 Nucleotide sequences coding polypeptide for use in the classification, diagnosis, prevention and treatment of downe's syndrome and alzheimers's diseases
11/14/2002	US20020169299 Gene for identifying individuals with familial dysautonomia
11/14/2002	US20020169295 Nucleotide sequences coding protein for use in the treatment, diagnosis and prevention of tumors and inflammatory bowel disease
11/14/2002	US20020169284 Nucleotide sequences coding polypeptide for use in the treatment of tumors, nervous system, virus, and visoin disorders

1 ... 2211 2212 2213 2214 2215 2216 2217 2218 2219 2220 2221 2222 2223 2224 2225 2226 2227 2228 2229 2230 2231 ... 3003